Extracted from this filing and checked against the source text.
Listing & Compliance Notices
SEC 8-K Item 3.01
confidence 0.9
AIM ImmunoTech Inc. received a nyse_american compliance regained notice regarding minimum bid price (rules 1003(f)(v)).
- Exchange
- nyse american
- Notice
- compliance regained
- Deficiency
- minimum bid price
- Rules
- 1003(f)(v)
Exact text from the filing
June 11, 2025, AIM ImmunoTech Inc. (the “Company”) was notified by The NYSE American (the “Exchange”) that the Company has regained compliance with Section 1003(f)(v) of the NYSE American Company Guide (low selling price) and that trading in the Company’s Common Stock is expected to be reinstated on the Exchange on June 17, 2025 and the ticker symbol will be “AIM” upon reinstatement. The Company’s Common Stock currently trades on the OTC Pink under the symbol “AIMID”. The new CUSIP is 00901B303.
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
AIM ImmunoTech Inc.: Filed amendment to Articles of Incorporation effecting a 1-for-100 reverse stock split (effective 2025-06-10).
- Change
- charter amendment
- Effective
- 2025-06-10
Exact text from the filing
On June 10, 2025, the Company filed an amendment to its Articles of Incorporation effecting a reverse split of its outstanding shares of Common Stock on a one for 100 basis
View on SEC.gov